| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Weiner Michael Hal | Chief Financial Officer | C/O GENPACT LLC, 521 FIFTH AVENUE, 14TH FLOOR, NEW YORK | /s/ Thomas D. Scholtes, as Attorney-in-fact for Michael Hal Weiner | 17 Nov 2025 | 0001591621 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | G | Common Shares | Sale | -$599K | -13.4K | -8.28% | $44.84 | 148K | 14 Nov 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.81 to $44.89. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F2 | Includes 169 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 13, 2025. The reporting person currently holds a total of 1,358 shares under the ESPP. |